Terms: = Endocrine gland cancer AND PLCG1, PLC1, 5335, ENSG00000124181, PLC-II, Plcg1, PLCgamma1, PLC148
15 results:
1. 8-Br-cGMP suppresses tumor progression through EGFR/PLC γ1 pathway in epithelial ovarian cancer.
Wu M; Mu C; Yang H; Wang Y; Ma P; Li S; Wang Z; Lan T
Mol Biol Rep; 2024 Jan; 51(1):140. PubMed ID: 38236447
[TBL] [Abstract] [Full Text] [Related]
2. The Pyroptosis-Related Gene Prognostic Index Associated with Tumor Immune Infiltration for Pancreatic cancer.
Xie W; Li X; Yang C; Li J; Shen G; Chen H; Xiao SY; Li Y
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682857
[TBL] [Abstract] [Full Text] [Related]
3. Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma.
Su K; Peng Y; Yu H
Dis Markers; 2022; 2022():9141117. PubMed ID: 35677632
[TBL] [Abstract] [Full Text] [Related]
4. BDNF activates TrkB/PLCγ1 signaling pathway to promote proliferation and invasion of ovarian cancer cells through inhibition of apoptosis.
Xu Y; Jiang WG; Wang HC; Martin T; Zeng YX; Zhang J; Qi YS
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5093-5100. PubMed ID: 31298409
[TBL] [Abstract] [Full Text] [Related]
5. Mesothelin and TGF-α predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib.
Poteet E; Liu D; Liang Z; Van Buren G; Chen C; Yao Q
PLoS One; 2019; 14(3):e0213294. PubMed ID: 30921351
[TBL] [Abstract] [Full Text] [Related]
6. Local Phototherapy Synergizes with Immunoadjuvant for Treatment of Pancreatic cancer through Induced Immunogenic Tumor Vaccine.
Zhou F; Yang J; Zhang Y; Liu M; Lang ML; Li M; Chen WR
Clin Cancer Res; 2018 Nov; 24(21):5335-5346. PubMed ID: 30068705
[No Abstract] [Full Text] [Related]
7. Identification of novel therapeutic target genes and pathway in pancreatic cancer by integrative analysis.
Hu B; Shi C; Jiang HX; Qin SY
Medicine (Baltimore); 2017 Oct; 96(42):e8261. PubMed ID: 29049217
[TBL] [Abstract] [Full Text] [Related]
8. sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.
Kim BR; Seo SH; Park MS; Lee SH; Kwon Y; Rho SB
Oncotarget; 2015 Oct; 6(31):31830-43. PubMed ID: 26378810
[TBL] [Abstract] [Full Text] [Related]
9. Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma.
Mahdi H; Xiu J; Reddy SK; DeBernardo R
J Surg Oncol; 2015 Aug; 112(2):188-94. PubMed ID: 26250968
[TBL] [Abstract] [Full Text] [Related]
10. Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer.
Timsah Z; Ahmed Z; Ivan C; Berrout J; Gagea M; Zhou Y; Pena GN; Hu X; Vallien C; Kingsley CV; Lu Y; Hancock JF; Liu J; Gladden AB; Mills GB; Lopez-Berestein G; Hung MC; Sood AK; Bogdanov M; Ladbury JE
Oncogene; 2016 Apr; 35(17):2186-96. PubMed ID: 26212011
[TBL] [Abstract] [Full Text] [Related]
11. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.
Block MS; Charbonneau B; Vierkant RA; Fogarty Z; Bamlet WR; Pharoah PD; ; ; ; Rossing MA; Cramer D; Pearce CL; Schildkraut J; Menon U; Kjaer SK; Levine DA; Gronwald J; Culver HA; Whittemore AS; Karlan BY; Lambrechts D; Wentzensen N; Kupryjanczyk J; Chang-Claude J; Bandera EV; Hogdall E; Heitz F; Kaye SB; Fasching PA; Campbell I; Goodman MT; Pejovic T; Bean YT; Hays LE; Lurie G; Eccles D; Hein A; Beckmann MW; Ekici AB; Paul J; Brown R; Flanagan JM; Harter P; du Bois A; Schwaab I; Hogdall CK; Lundvall L; Olson SH; Orlow I; Paddock LE; Rudolph A; Eilber U; Dansonka-Mieszkowska A; Rzepecka IK; Ziolkowska-Seta I; Brinton LA; Yang H; Garcia-Closas M; Despierre E; Lambrechts S; Vergote I; Walsh CS; Lester J; Sieh W; McGuire V; Rothstein JH; Ziogas A; Lubiński J; Cybulski C; Menkiszak J; Jensen A; Gayther SA; Ramus SJ; Gentry-Maharaj A; Berchuck A; Wu AH; Pike MC; Van Den Berg D; Terry KL; Vitonis AF; Ramirez SM; Rider DN; Knutson KL; Sellers TA; Phelan CM; Doherty JA; Johnatty SE; deFazio A; Song H; Tyrer J; Kalli KR; Fridley BL; Cunningham JM; Goode EL
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1421-7. PubMed ID: 24740199
[TBL] [Abstract] [Full Text] [Related]
12. Down-regulation of miR-218-2 and its host gene SLIT3 cooperate to promote invasion and progression of thyroid cancer.
Guan H; Wei G; Wu J; Fang D; Liao Z; Xiao H; Li M; Li Y
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1334-44. PubMed ID: 23720784
[TBL] [Abstract] [Full Text] [Related]
13. Effects of HER2-binding affibody molecules on intracellular signaling pathways.
Ekerljung L; Steffen AC; Carlsson J; Lennartsson J
Tumour Biol; 2006; 27(4):201-10. PubMed ID: 16651854
[TBL] [Abstract] [Full Text] [Related]
14. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.
Iuliano R; Trapasso F; Le Pera I; Schepis F; Samà I; Clodomiro A; Dumon KR; Santoro M; Chiariotti L; Viglietto G; Fusco A
Cancer Res; 2003 Feb; 63(4):882-6. PubMed ID: 12591742
[TBL] [Abstract] [Full Text] [Related]
15. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.
Sugimoto T; Kuroda H; Horii Y; Moritake H; Tanaka T; Hattori S
Jpn J Cancer Res; 2001 Feb; 92(2):152-60. PubMed ID: 11223544
[TBL] [Abstract] [Full Text] [Related]